-
1.
公开(公告)号:US11168073B2
公开(公告)日:2021-11-09
申请号:US16712660
申请日:2019-12-12
申请人: YUHAN CORPORATION
发明人: Tae Dong Han , Hee Jae Tak , Eun Kyung Kim , Eui Chul Lee , Sol Park , Hyok Jun Cho , Cheol Hee Lim , So Young Kim , Hyun Ho Choi , Da Na Jeong , Na Yeon Yang , Na Ry Ha
IPC分类号: C07D403/10 , C07D249/12 , C07D401/04 , C07D401/10 , C07D401/14 , C07D403/04 , C07D403/14 , C07D405/10 , C07D405/14 , C07D409/06 , C07D409/14 , C07D413/14
摘要: The present technology provides 3,3-difluoroallylamines or pharmaceutically acceptable salts thereof, preparation processes thereof, pharmaceutical compositions comprising the same, and uses thereof. The 3,3-difluoroallylamines or their pharmaceutically acceptable salts exhibit potent inhibitory activity on VAP-1 and therefore can be usefully applied, e.g., for the treatment and prophylaxis of nonalcoholic hepatosteatosis (NASH).
-
2.
公开(公告)号:US11713308B2
公开(公告)日:2023-08-01
申请号:US17368738
申请日:2021-07-06
申请人: YUHAN CORPORATION
发明人: Tae Dong Han , Hee Jae Tak , Eun Kyung Kim , Eui Chul Lee , Sol Park , Hyok Jun Cho , Cheol Hee Lim , So Young Kim , Hyun Ho Choi , Da Na Jeong , Na Yeon Yang , Na Ry Ha
IPC分类号: C07D403/10 , C07D249/12 , C07D401/04 , C07D401/10 , C07D401/14 , C07D403/04 , C07D403/14 , C07D405/10 , C07D405/14 , C07D409/06 , C07D409/14 , C07D413/14
CPC分类号: C07D403/10 , C07D249/12 , C07D401/04 , C07D401/10 , C07D401/14 , C07D403/04 , C07D403/14 , C07D405/10 , C07D405/14 , C07D409/06 , C07D409/14 , C07D413/14
摘要: The present technology provides 3,3-difluoroallylamines or pharmaceutically acceptable salts thereof, preparation processes thereof, pharmaceutical compositions comprising the same, and uses thereof. The 3,3-difluoroallylamines or their pharmaceutically acceptable salts exhibit potent inhibitory activity on VAP-1 and therefore can be usefully applied, e.g., for the treatment and prophylaxis of nonalcoholic hepatosteatosis (NASH).
-
3.
公开(公告)号:US10995086B2
公开(公告)日:2021-05-04
申请号:US16359985
申请日:2019-03-20
申请人: YUHAN CORPORATION
发明人: Tae Dong Han , Hee Jae Tak , Eun Kyung Kim , Su Bin Choi , Sol Park , Dong Hoon Kim , So Young Kim , Hyun Ho Choi , Tae Wang Kim , Mi Kyeong Ju , Na Ry Ha , Eui Chul Lee
IPC分类号: C07D409/06 , C07D409/04 , C07D409/14 , C07D498/04 , C07D413/14 , C07D471/04 , C07D405/14
摘要: The present technology provides triazolone derivatives or pharmaceutically acceptable salts thereof, preparation processes thereof, pharmaceutical compositions comprising the same, and the use thereof. The triazolone derivatives or their pharmaceutically acceptable salts exhibit selective inhibitory activity on VAP-1 and therefore can be usefully applied, e.g., for the treatment and prophylaxis of nonalcoholic hepatosteatosis (NASH).
-
-